Trimedyne, Inc. announced that Robert S. Cowles, III, M.D. has agreed to serve as Medical Director of the company. He will review company's new technologies and advise. Trimedyne on the design of the clinical trials to be conducted, subject to receipt of funding, by the seven subsidiaries.

Dr. Cowles is an accomplished surgeon and a highly respected Urologist who has lectured throughout the world on the use of lasers and other technologies in Urology. He was the first Urologist in the United States to use the first laser and side firing, fiber-optic device to treat benign prostate hyperplas. Dr. Cowles is Chairman of the Cowles Clinic.